Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 255, doi. 10.1007/s00125-015-3749-7
- By:
- Publication type:
- Article
Works matching IS 0012186X AND DT 2016 AND VI 59 AND IP 2
Results: 25
1
2
Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 307, doi. 10.1007/s00125-015-3788-0
- By:
- Publication type:
- Article
3
Antihypertensive medication prior to nocturnal sleep reduces the risk of new-onset type 2 diabetes in hypertensive patients: a role for slow-wave sleep?
- Published in:
- 2016
- By:
- Publication type:
- Letter
4
Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 294, doi. 10.1007/s00125-015-3792-4
- By:
- Publication type:
- Article
5
Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 363, doi. 10.1007/s00125-015-3794-2
- By:
- Publication type:
- Article
6
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 266, doi. 10.1007/s00125-015-3795-1
- By:
- Publication type:
- Article
7
Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 299, doi. 10.1007/s00125-015-3802-6
- By:
- Publication type:
- Article
8
Association of the average rate of change in HbA with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 286, doi. 10.1007/s00125-015-3797-z
- By:
- Publication type:
- Article
9
Cardiac Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 371, doi. 10.1007/s00125-015-3799-x
- By:
- Publication type:
- Article
10
Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 237, doi. 10.1007/s00125-015-3800-8
- By:
- Publication type:
- Article
11
Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 341, doi. 10.1007/s00125-015-3801-7
- By:
- Publication type:
- Article
12
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 379, doi. 10.1007/s00125-015-3796-0
- By:
- Publication type:
- Article
13
Influence of HLA-DR and - DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 334, doi. 10.1007/s00125-015-3803-5
- By:
- Publication type:
- Article
14
The impact of gender on the long-term morbidity and mortality of patients with type 2 diabetes receiving structured personal care: a 13 year follow-up study.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 275, doi. 10.1007/s00125-015-3804-4
- By:
- Publication type:
- Article
15
Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 316, doi. 10.1007/s00125-015-3805-3
- By:
- Publication type:
- Article
16
Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
17
RBP4 functions as a hepatokine in the regulation of glucose metabolism by the circadian clock in mice.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 354, doi. 10.1007/s00125-015-3807-1
- By:
- Publication type:
- Article
18
Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 325, doi. 10.1007/s00125-015-3808-0
- By:
- Publication type:
- Article
19
Night-time blood pressure: a role in the prediction and prevention of diabetes?
- Published in:
- 2016
- By:
- Publication type:
- Letter
20
Erratum to: Impaired mitochondrial oxidative phosphorylation and supercomplex assembly in rectus abdominis muscle of diabetic obese individuals.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
21
Novel approaches to treating type 2 diabetes.
- Published in:
- 2016
- By:
- Publication type:
- Letter
22
G protein-coupled receptors as new therapeutic targets for type 2 diabetes.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 229, doi. 10.1007/s00125-015-3825-z
- By:
- Publication type:
- Article
23
Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention.
- Published in:
- 2016
- By:
- Publication type:
- Letter
24
Up front February 2016.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 225, doi. 10.1007/s00125-015-3834-y
- Publication type:
- Article
25
Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 244, doi. 10.1007/s00125-015-3748-8
- By:
- Publication type:
- Article